Press Releases
- Titan Pharmaceuticals Announces Enrollment Reaches Halfway Mark in Phase 3 Study of Probuphine for Opioid Dependence
- BIO Joins AdvaMed, PhRMA in Letter Expressing Concerns With Sunshine Act Implementation
- FierceBiotech names Navitor Pharmaceuticals as one of its "Fierce 15" Biotech Companies of 2014
- Nexstim Plans an Initial Public Offering on NASDAQ OMX First North
- Threshold Pharmaceuticals Announces Its Phase 3 Trial of TH-302 in Patients With Advanced Soft Tissue Sarcoma Will Continue as Planned Following Protocol-Specified Interim Analysis
- More Press Releases
Featured Jobs
> Need a job? Need to hire? Visit our jobs site.

